Compare SAH & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAH | TMDX |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 3.9B |
| IPO Year | 1997 | 2019 |
| Metric | SAH | TMDX |
|---|---|---|
| Price | $62.86 | $122.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $80.75 | ★ $144.25 |
| AVG Volume (30 Days) | 197.2K | ★ 744.0K |
| Earning Date | 02-11-2026 | 10-29-2025 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | N/A | ★ 170.70 |
| EPS | ★ 3.73 | 2.54 |
| Revenue | ★ $15,178,100,000.00 | $566,354,000.00 |
| Revenue This Year | $7.94 | $38.81 |
| Revenue Next Year | $3.35 | $20.49 |
| P/E Ratio | ★ $17.07 | $48.53 |
| Revenue Growth | 9.09 | ★ 41.20 |
| 52 Week Low | $52.00 | $55.00 |
| 52 Week High | $89.62 | $156.00 |
| Indicator | SAH | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 43.30 | 42.00 |
| Support Level | $63.55 | $120.82 |
| Resistance Level | $65.44 | $133.29 |
| Average True Range (ATR) | 1.78 | 5.25 |
| MACD | -0.08 | -0.94 |
| Stochastic Oscillator | 5.04 | 16.66 |
Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores, 16 collision centers, and 14 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 59% of new-vehicle revenue. BMW is the largest brand at about 25%. 2024's revenue was $14.2 billion, with Texas and California comprising 51% of the total. EchoPark's portion was $2.1 billion.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.